Shares of Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) have received an average recommendation of “Moderate Buy” from the seventeen analysts that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, six have given a hold rating and ten have issued a buy rating on the company. The average 1-year price target among analysts that have covered the stock in the last year is $43.19.
BBWI has been the subject of several recent research reports. JPMorgan Chase & Co. boosted their price target on shares of Bath & Body Works from $39.00 to $41.00 and gave the stock a “neutral” rating in a research note on Friday, January 24th. Barclays boosted their target price on Bath & Body Works from $28.00 to $34.00 and gave the company an “underweight” rating in a research note on Tuesday, November 26th. TD Cowen raised their price target on Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th. Morgan Stanley lowered their price objective on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research report on Thursday, November 21st. Finally, Argus restated a “hold” rating on shares of Bath & Body Works in a report on Friday, January 10th.
Read Our Latest Analysis on Bath & Body Works
Institutional Investors Weigh In On Bath & Body Works
Bath & Body Works Stock Down 3.5 %
NYSE BBWI opened at $37.41 on Friday. The stock’s 50-day simple moving average is $37.75 and its two-hundred day simple moving average is $33.67. Bath & Body Works has a twelve month low of $26.20 and a twelve month high of $52.99. The company has a market capitalization of $8.10 billion, a price-to-earnings ratio of 9.12, a PEG ratio of 1.01 and a beta of 1.83.
Bath & Body Works (NYSE:BBWI – Get Free Report) last released its earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, topping analysts’ consensus estimates of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The company had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter in the previous year, the company posted $0.48 EPS. Bath & Body Works’s quarterly revenue was up 3.1% compared to the same quarter last year. On average, equities analysts expect that Bath & Body Works will post 3.26 earnings per share for the current fiscal year.
Bath & Body Works Company Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Recommended Stories
- Five stocks we like better than Bath & Body Works
- Investing In Preferred Stock vs. Common Stock
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- What Investors Need to Know About Upcoming IPOs
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.